Brandinium

Trademark search for:

PHARMACRYST

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results
Also check across: EU CA AU NZ CH

USPTO Filing History

Key events recorded for this trademark application

  • 2005-12-27 — Application filed
  • 2006-01-04 — Application filed
  • 2006-06-22 — Final disposition recorded
  • 2006-06-22 — Final disposition recorded
  • 2006-06-22 — Assigned to examiner
  • 2006-12-12 — Paper received
  • 2007-01-16 — Suspension letter written
  • 2007-01-16 — Letter of suspension e-mailed
  • 2007-01-16 — Amendment from applicant entered
  • 2007-01-16 — Assigned to lie
  • 2007-01-16 — Correspondence received in law office
  • 2007-07-16 — Suspension inquiry written
  • 2007-07-16 — Inquiry to suspension e-mailed
  • 2007-07-16 — Notification of inquiry as to suspension e-mailed
  • 2008-01-10 — Paper received
  • 2008-01-14 — Assigned to lie
  • 2008-01-16 — Suspension letter written
  • 2008-01-16 — Letter of suspension e-mailed
  • 2008-01-16 — Notification of letter of suspension e-mailed
  • 2008-01-16 — Amendment from applicant entered
  • 2008-01-16 — Correspondence received in law office
  • 2008-07-17 — Suspension inquiry written
  • 2008-07-17 — Inquiry to suspension e-mailed
  • 2008-07-17 — Notification of inquiry as to suspension e-mailed
  • 2009-02-12 — Application abandoned
  • 2009-02-12 — Application abandoned
  • 2009-02-26 — Office action issued
  • 2009-02-26 — Petition to revive-granted
  • 2009-02-26 — Teas petition to revive received
  • 2009-02-27 — Suspension letter written
  • 2009-02-27 — Letter of suspension e-mailed
  • 2009-02-27 — Notification of letter of suspension e-mailed
  • 2009-02-27 — Teas/email correspondence entered
  • 2009-02-27 — Correspondence received in law office
  • 2009-08-27 — Suspension inquiry written
  • 2009-08-27 — Inquiry to suspension e-mailed
  • 2009-08-27 — Notification of inquiry as to suspension e-mailed
  • 2009-08-27 — Suspension checked - to attorney for action
  • 2010-01-04 — Assigned to examiner
  • 2010-02-03 — Automatic update of assignment of ownership
  • 2010-02-26 — Attorney/dom.rep.revoked and/or appointed
  • 2010-02-26 — Suspension letter written
  • 2010-02-26 — Letter of suspension e-mailed
  • 2010-02-26 — Notification of letter of suspension e-mailed
  • 2010-02-26 — Teas revoke/app/change addr of atty/dom rep received
  • 2010-08-26 — Suspension inquiry written
  • 2010-08-26 — Inquiry to suspension e-mailed
  • 2010-08-26 — Notification of inquiry as to suspension e-mailed
  • 2010-08-26 — Teas change of correspondence received
  • 2010-10-13 — Assigned to examiner
  • 2011-02-28 — Teas response to suspension inquiry received
  • 2011-02-28 — Correspondence received in law office
  • 2011-03-01 — Teas/email correspondence entered
  • 2011-03-10 — Approved for pub - principal register
  • 2011-03-26 — Assigned to lie
  • 2011-03-26 — Law office publication review completed
  • 2011-05-03 — Published for opposition
  • 2011-05-03 — Official gazette publication confirmation e-mailed
  • 2011-06-28 — Noa e-mailed - sou required from applicant
  • 2012-01-30 — Application abandoned
  • 2012-01-30 — Application abandoned
  • 2012-01-30 — Final status recorded

Owner Information

SMITH & NEPHEW (OVERSEAS) LIMITED
LONDON GB
SMITH & NEPHEW (OVERSEAS) LIMITED
LONDON GB
Nucryst Pharmaceuticals Corp.
Fort Saskatchewan, Alberta CA

Correspondent

CHRISTOPHER P. BUSSERT KILPATRICK STOCKTON LLP
1100 PEACHTREE ST NE
STE 2800
ATLANTA, GA 30309-4530

Filing Details

Filing Date:
2005-12-27
Status Date:
2012-01-30
Category:
Pharmaceuticals
Filing Year:
2005

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.